Figure 5. Enrichment analysis of IPM. (A) Correlation between the risk score and the expression level of immune checkpoints genes. (B–F) The expression level of immune checkpoints genes in the high and low risk MIBC patients. (G) Heatmap plot of immune-associated genes that were differentially expressed between the high and low risk MIBC patients. (H) Enrichment of biological processes for immune-associated genes that are shown in the circular plot. (I) Enrichment of KEGG pathways for immune-associated genes that are shown in the sankey plot.